TAK logo

TAK R&D Expenses

Latest reported¥167.40B JPY
TAK Quarterly R&D Expenses · JPY (¥86.24B → ¥167.40B)
High-resolution chart · PNG

TAK r&d expenses history

Quarterly · JPY. Dates are reporting period ends; fiscal years can differ from calendar years.

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) R&D Expenses — Quarterly (JPY)
Period endingR&D Expenses (JPY)
167,395,000,000
198,908,242,000
178,394,386,000
161,482,000,000
143,891,000,000
216,000,000,000
170,193,000,000
175,564,000,000
168,463,000,000
195,856,000,000
187,381,000,000
183,946,000,000
162,741,000,000
160,944,000,000
174,629,000,000
154,145,000,000
143,607,000,000
143,628,000,000
128,378,000,000
131,600,000,000
122,480,000,000
113,289,000,000
117,566,000,000
118,157,000,000
106,821,000,000
139,309,000,000
122,709,000,000
113,497,000,000
116,866,000,000
139,405,000,000
77,461,000,000
79,466,000,000
71,966,000,000
88,782,000,000
81,564,000,000
79,408,000,000
75,688,000,000
88,504,000,000
71,833,000,000
75,416,000,000
76,550,000,000
92,029,000,000
92,525,000,000
80,382,000,000
80,991,000,000
132,869,000,000
92,708,000,000
81,363,000,000
75,155,000,000
103,366,000,000
83,105,000,000
76,641,000,000
77,546,000,000
92,718,000,000
76,897,000,000
75,799,000,000
78,878,000,000
0
70,737,000,000
61,286,000,000
57,715,000,000
0
65,806,000,000
62,082,000,000
62,113,000,000
0
73,698,000,000
70,714,000,000
64,867,000,000
0
56,531,000,000
86,237,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.